Skip to main content

Advertisement

ADVERTISEMENT

Interviews

Alex Kilgore, PharmD, product manager, global products & solutions, AmerisourceBerge
Interview
03/15/2023
“There is need for additional support to keep the patient engaged and empowered to take ownership and an active role in their health care. I think digital therapeutics are a way to start to bridge that gap where we can have that continuous...
“There is need for additional support to keep the patient engaged and empowered to take ownership and an active role in their health care. I think digital therapeutics are a way to start to bridge that gap where we can have that continuous...
“There is need for additional...
03/15/2023
First Report Managed Care
Headshot of Jason Burum, Wolters Kluwer
Interview
01/26/2023
“Even a small improvement on engagement translates into huge impacts on outcomes and satisfaction, which also means cost savings for the whole industry,” says Jason Burum, general manager, Provider Segment, Clinical Effectiveness, Wolters...
“Even a small improvement on engagement translates into huge impacts on outcomes and satisfaction, which also means cost savings for the whole industry,” says Jason Burum, general manager, Provider Segment, Clinical Effectiveness, Wolters...
“Even a small improvement on...
01/26/2023
First Report Managed Care

Advertisement

Headshot of Dr Genevieve Neal-Perry, UNC Chapel Hill
Interview
01/23/2023
Genevieve Neal-Perry, MD, PhD, chair, department of obstetrics and gynecology, University of North Carolina Chapel Hill, shares phase 3 data on the efficacy and side effect profile of fezolinetant for patients with severe vasomotor symptoms...
Genevieve Neal-Perry, MD, PhD, chair, department of obstetrics and gynecology, University of North Carolina Chapel Hill, shares phase 3 data on the efficacy and side effect profile of fezolinetant for patients with severe vasomotor symptoms...
Genevieve Neal-Perry, MD, PhD,...
01/23/2023
First Report Managed Care
Headshot of Dr Hira Shaikh, University of Iowa
Interview
01/19/2023
Hira Shaikh, MD, assistant professor of hematology, oncology, and bone marrow transplant, University of Iowa Hospitals and Clinics, walks through the details of her study which compared multiple myeloma survival outcomes among Hispanic vs...
Hira Shaikh, MD, assistant professor of hematology, oncology, and bone marrow transplant, University of Iowa Hospitals and Clinics, walks through the details of her study which compared multiple myeloma survival outcomes among Hispanic vs...
Hira Shaikh, MD, assistant...
01/19/2023
First Report Managed Care
Headshot of John Fryer, Tribus and Lumeris
Interview
01/03/2023
John Fryer, president, Tribus, and senior vice president of national markets, Lumeris, offers insight into challenges providers have come up against when switching from fee-for-service to value-based payment models and shares how accelerated...
John Fryer, president, Tribus, and senior vice president of national markets, Lumeris, offers insight into challenges providers have come up against when switching from fee-for-service to value-based payment models and shares how accelerated...
John Fryer, president, Tribus,...
01/03/2023
Integrated Healthcare Executive

Advertisement

Headshot of Morris Panner, Intelerad
Interview
12/06/2022
Morris Panner, JD, president, Intelerad, discusses the mammography and lung cancer diagnostics markets, as well as the effect of technology expansions on care from both patient and payer perspectives.
Morris Panner, JD, president, Intelerad, discusses the mammography and lung cancer diagnostics markets, as well as the effect of technology expansions on care from both patient and payer perspectives.
Morris Panner, JD, president,...
12/06/2022
Integrated Healthcare Executive
Headshot of Nikolaos Sideris, Aristotle University, Thessaloniki, Greece
Interview
11/01/2022
Nikolaos Sideris, MD, PhD candidate-scientific associate, First Department of Dermatology, Aristotle University Medical School, Thessaloniki, Greece, reviews the current state of practice and research in atopic dermatitis, emphasizing the...
Nikolaos Sideris, MD, PhD candidate-scientific associate, First Department of Dermatology, Aristotle University Medical School, Thessaloniki, Greece, reviews the current state of practice and research in atopic dermatitis, emphasizing the...
Nikolaos Sideris, MD, PhD...
11/01/2022
First Report Managed Care
Headshot of Omar Dabbous, MD, MPH
Interview
10/24/2022
“Current treatment options for SMA are revolutionary to the patients in need, and additional data—apart from safety and efficacy evidence from clinical trials—can help more comprehensively inform payers in their decision making,” said Omar...
“Current treatment options for SMA are revolutionary to the patients in need, and additional data—apart from safety and efficacy evidence from clinical trials—can help more comprehensively inform payers in their decision making,” said Omar...
“Current treatment options for...
10/24/2022
First Report Managed Care

Advertisement

Headshot of Joshua Richter, MD, Mount Sinai
Interview
10/18/2022
Joshua Richter, MD, associate professor of medicine, hematology, and oncology, Tisch Cancer Institute, Icahn School of Medicine, Mount Sinai, reviews real-world data presented at the SOHO 2022 Annual Meeting in which combination bortezomib,...
Joshua Richter, MD, associate professor of medicine, hematology, and oncology, Tisch Cancer Institute, Icahn School of Medicine, Mount Sinai, reviews real-world data presented at the SOHO 2022 Annual Meeting in which combination bortezomib,...
Joshua Richter, MD, associate...
10/18/2022
First Report Managed Care
Headshot of Srdan Verstovsek, MD Anderson Cancer Center, TX
Interview
10/18/2022
Srdan Verstovsek, MD, PhD, professor of medicine, Leukemia Department, MD Anderson Cancer Center at Houston, Texas, shares research from the SOHO 2022 Annual Meeting in which he reviewed the burden of myelofibrosis and promising agents...
Srdan Verstovsek, MD, PhD, professor of medicine, Leukemia Department, MD Anderson Cancer Center at Houston, Texas, shares research from the SOHO 2022 Annual Meeting in which he reviewed the burden of myelofibrosis and promising agents...
Srdan Verstovsek, MD, PhD,...
10/18/2022
First Report Managed Care

Advertisement